back to homepage

Press Release

Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024

DelveInsight’s, “Acute Lymphocytic Leukemia Pipeline Insight 2024” report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in the Acute Lymphocytic Leukemia pipeline landscape. It covers the Acute Lymphocytic

Read More

Non-Small Cell Lung Cancer Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2024

DelveInsight’s, “Non-Small-Cell Lung Cancer Pipeline Insight 2024” report provides comprehensive insights about 135+ Non-Small Cell Lung Cancer Companies and 150+ pipeline drugs in the Non-Small-Cell Lung cancer (NSCLC) pipeline landscape.

Read More

Non-Hodgkin Lymphoma Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2024 (Updated)

DelveInsight’s, “Non-Hodgkin Lymphoma Pipeline Insight 2024” report provides comprehensive insights about 200+ Non-Hodgkin Lymphoma companies and 220+ pipeline drugs in the Non-Hodgkin Lymphoma pipeline landscape. It covers the Non-Hodgkin Lymphoma

Read More

Zurich Designer Ketty Nunez of Kenu Boutique Makes Sensational EPN New York Fashion Week Debut with her “Storm of Calm” Collection

Zurich-based designer Ketty Nunez, the creative mind behind Kenu Boutique, recently captured the spotlight at New York Fashion Week (NYFW) with her highly anticipated debut collection titled “Storm of Calm.”

Read More

Rosai-Dorfman Disease Market to Witness Upsurge in Growth During (2019-2032), by DelveInsight | Teva Pharma, Zydus Pharmaceuticals, Advanz Pharmaceticals, Novartis, Mylan N.V., Aurobindo Pharma

DelveInsight’s “Rosai-Dorfman Disease Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Rosai-Dorfman Disease, historical and forecasted epidemiology as well as the Rosai-Dorfman Disease market trends in

Read More

OWNx Unveils Revolutionary Precious Metals IRA with Zero Premiums and No Minimum Investment

Transforming the Precious Metals Investment Landscape: OWNx’s Latest Offering Promises More Metal, Less Hype, and Unprecedented Accessibility. Lawrence, Kansas – Feb 21, 2024 – OWNx, a leading innovator in the

Read More

Pseudoxanthoma Elasticum Market to Witness Growth by 2032, Estimates DelveInsight | Companies – Daiichi Sankyo, PXE International, Inozyme Pharma, others

Pseudoxanthoma Elasticum Market DelveInsight’s “Pseudoxanthoma Elasticum Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Pseudoxanthoma Elasticum, historical and forecasted epidemiology as well as the Pseudoxanthoma Elasticum

Read More

Kathleen Cameron Selected as Top Business Innovator of the Year by IAOTP

Kathleen Cameron, Entrepreneur, Role Model, Best-Selling Author, World-Famous Manifestation Coach, Speaker, and Founder of Diamond Academy Coaching Inc. was recently selected as Top Business Innovator of the Year for 2024

Read More

Intermittent Claudication Market to Witness Growth by 2032, Estimates DelveInsight | DNAVEC Corporation, Nuo Therapeutics, Kowa Company, LTT Bio-Pharma, Pluristem Therapeutics, ID Pharma, Bayer

Intermittent Claudication Market DelveInsight’s “Intermittent Claudication Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Intermittent Claudication, historical and forecasted epidemiology as well as the Intermittent Claudication

Read More

NYC Commercial Real Estate Attorney Peter Zinkovetsky Releases Essential Guide on Commercial Leasing

NYC commercial real estate attorney Peter Zinkovetsky (https://www.avenuelawfirm.com/things-consider-signing-commercial-lease-nyc/) of Avenue Law Firm has recently published an insightful article aimed at aiding new business owners in the complex process of signing

Read More

Biotech Innovation: Coeptis Therapeutics (COEP) And 3 Companies Changing The Game

Coeptis Therapeutics Holding Inc. (NASDAQ: COEP) is a biopharmaceutical company making waves in the world of cell therapy, particularly focusing on allogeneic approaches for cancer and other serious diseases. Led

Read More

Primary Hyperoxaluria Market is Anticipated to show Robust Growth by 2032, Evaluated by DelveInsight | Companies Include Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera, Allena Pharma

Primary Hyperoxaluria Market DelveInsight’s “Primary Hyperoxaluria Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Primary Hyperoxaluria, historical and forecasted epidemiology as well as the Primary Hyperoxaluria

Read More